ASCVD is a major cause of morbidity and mortality in the United States. In fact, 8% of the US population has ASCVD, and the disease is responsible for an estimated cost of >$200 billion annually in healthcare services, medications, and lost productivity. In an effort to drive improvement in ASCVD care, the CDC’s Division for Heart Disease and Stroke Prevention published the Million Hearts®/National Association of Community Health Centers/American Medical Association Cholesterol Management Change Package (CMCP). This resource presents a list of evidence-based process improvements that outpatient clinical settings can implement to seek optimal cholesterol management. Azara Healthcare was fortunate enough to collaborate with the CDC on this effort and is thrilled to have had the opportunity to highlight strategies for leveraging DRVS to advance ASCVD care delivery.
